The Onset Time of Rocuronium in Emergency & Elective Surgery

Status Not yet recruiting

Clinical Trial Summary

Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds after intravenous injection, patients can be intubated.

Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of this study is to investigate the effect of patient anxiety levels on the onset time of rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.

Clinical Trial Description

After obtaining ethics committee approval, American Society of Anesthesiologists physiological status 1 (ASA 1) patients, undergoing elective inguinal hernia repair and acute appendectomy, will be included to trial.

Patients will be taken to the operating room without premedication. Spielberger's State-Trait Anxiety Inventory (STAI) will be administered to patients for determining anxiety level.

Electrocardiogram, blood pressure and peripheric oxygen saturation (SpO2) will be monitored. After opening intravenous access on hand dorsum, ringer lactate solution will be given. Neuromuscular monitoring and drug injections will be done as described in "Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents".

TOF-Guard SX acceleromyograph (Organon-Teknika) will be monitored on corrugator supercilii muscle because of its sensitivity to laryngeal muscles. In induction of anesthesia, propofol 2 mg kg-1 and fentanyl 1 mcg kg-1 will be administered intravenously. After loss of conscious, TOF-Guard SX will be calibrated and then 0.6 mg kg-1 rocuronium will be administered in 5 seconds. 20 milliampere (mA) current TOF stimulation (200 ms, square wave, 2 Hz for 1.5 s) will be repeated in every 15 s. Patients will be intubated in TOF 0.1 time.

STAI score, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, SpO2, TOF 0.1 time and intubation conditions will be compared between two groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02634255
Study type	Interventional
Source	Diskapi Yildirim Beyazit Education and Research Hospital
Contact	Gamze Gulgun, Md
Phone	+905308705073
Email	dr.gamzegulgun@yahoo.com
Status	Not yet recruiting
Phase	Phase 3
Start date	December 2015
Completion date	July 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03023462` - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair	N/A
Completed	`NCT04272320` - The Efficacy of Transversalis Fascia Plane Block in Pediatric Inguinal Hernia Repair	N/A
Recruiting	`NCT03904888` - Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair	N/A
Recruiting	`NCT03856710` - Self Fixating Versus Stapled Mesh for Laparoscopic Inguinal Hernia Repair	N/A
Completed	`NCT02240550` - A Comparative Clinical Study to Evaluate the Effectiveness of ProFlor vs. Lichtenstein for Inguinal Hernia Repair	N/A
Completed	`NCT01943760` - Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty	Phase 4
Completed	`NCT01679353` - Comparison of Analgesic Effect of Magnesium Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia on Postoperative Pain Control in Pediatric Patients Undergoing Inguinal Hernia Repair	N/A
Recruiting	`NCT01450345` - Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain	Phase 3
Active, not recruiting	`NCT00968773` - Rebound Hernia Repair Device Mesh Trial	Phase 4
Completed	`NCT01000116` - Fibrin Glue Versus Tacked Fixation in Groin Hernia Repair (TAPP)	N/A
Completed	`NCT01117337` - Comparing Non-fixation of Mesh to Mesh Fixation in Laparoscopic Inguinal Hernia Repair	Phase 4
Terminated	`NCT00226161` - Chronic Pain After Inguinal Herniorrhaphy	N/A
Completed	`NCT05837013` - Open and Laparoscopic Total Extraperitoneal Repair Under Spinal Anesthesia Versus General Anesthesia	N/A
Recruiting	`NCT05058378` - Correlation Between Spinal Anesthesia and Perfusion Index
Completed	`NCT01637818` - Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair	N/A
Recruiting	`NCT05879770` - Is the Use of Prolene as Sufficient as the Use of Wire in Shouldice Surgery to Keep the Recurrence Rate Low After One Year?
Completed	`NCT05159232` - Length of Hospital Stay in Laparoscopic Transabdominal Preperitoneal Vs. Open Mesh Repair in Inguinal Hernia: A Randomised Controlled Trial	N/A
Completed	`NCT05107986` - Laparoscopy in Complicated Groin Hernia
Active, not recruiting	`NCT04328597` - Portuguese Inguinal Hernia Cohort (PINE) Study
Completed	`NCT04033055` - Antalgic Efficacy of CycloMesh™ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Onset Time of Rocuronium in Emergency and Elective Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms